AIG
DYN icon

American International Group’s Dyne Therapeutics DYN Stock Holding History

American International Group’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-29,138
Closed -$827K – 803
2024
Q1 		$827K Buy
29,138
+7,027
+32% +$159K ﹤0.01% 1400
2023
Q4 		$294K Buy
22,111
+899
+4% +$8.78K ﹤0.01% 1950
2023
Q3 		$190K Buy
21,212
+754
+4% +$8.12K ﹤0.01% 2153
2023
Q2 		$230K Buy
20,458
+5,169
+34% +$61K ﹤0.01% 2085
2023
Q1 		$176K Buy
15,289
+305
+2% +$3.96K ﹤0.01% 2188
2022
Q4 		$174K Sell
14,984
-55
-0.4% -$636 ﹤0.01% 2201
2022
Q3 		$191K Buy
15,039
+212
+1% +$2.43K ﹤0.01% 2180
2022
Q2 		$102K Sell
14,827
-83
-0.6% -$572 ﹤0.01% 2586
2022
Q1 		$144K Sell
14,910
-1,049
-7% -$8.93K ﹤0.01% 2430
2021
Q4 		$190K Sell
15,959
-478
-3% -$6.72K ﹤0.01% 2404
2021
Q3 		$267K Sell
16,437
-391
-2% -$6.93K ﹤0.01% 2246
2021
Q2 		$354 Buy
16,828
+7,439
+79% +$140K ﹤0.01% 2147
2021
Q1 		$146 Buy
9,389
+1,116
+13% +$21.6K ﹤0.01% 2529
2020
Q4 		$174 Buy
+8,273
New +$164K ﹤0.01% 2355

Other funds holding DYN

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

American International Group's DYN Position: Q2 2024 in Review

American International Group sold out of Dyne Therapeutics (DYN) in Q2 2024, closing a stake of 29,138 shares — an estimated $827K sold.

American International Group first reported a position in DYN in Q4 2020 and held it in 14 quarters. The position peaked at $827K in Q1 2024. 193 funds tracked by Wall St. Rank hold DYN as of Q2 2024.

  • American International Group reported no remaining Dyne Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 29,138 Dyne Therapeutics shares in Q2 2024, an estimated $827K.
  • American International Group first reported a position in Dyne Therapeutics in Q4 2020 and held it in 14 quarters.
  • American International Group's Dyne Therapeutics position peaked at $827K in Q1 2024.
  • 193 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.